U.S. Pot Industry Faces Antitrust Overhang: Cannabis Weekly
- Department of Justice reviews takeovers in fragmented industry
- ‘I think it will be a grinding process,’ iAnthus CEO says
This article is for subscribers only.
The U.S. cannabis industry is highly fragmented, yet at least six acquisitions are languishing in the purgatory of Department of Justice antitrust reviews.
It’s ironic, as there’s certainly no risk of a cannabis cartel forming anytime soon. It’s also one of the primary reasons that many publicly traded U.S. cannabis companies have fallen 40% to 50% from their 2019 highs.